Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvovaginal Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05074602
What this trial is testing

Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Jiangsu HengRui Medicine Co., Ltd. 196
Not applicableUnknownNCT04713917
What this trial is testing

Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris 330
Early research (Phase 1)Study completedNCT06954493
What this trial is testing

Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp

Who this might be right for
Vulvovaginal CandidiasisCandida InfectionVaginal Candidiasis
Scynexis, Inc. 5
Not applicableEnded earlyNCT02859493
What this trial is testing

Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

Who this might be right for
Candidiasis, Vulvovaginal
Lesaffre International 80
Testing effectiveness (Phase 2)WithdrawnNCT05031481
What this trial is testing

Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

Who this might be right for
Vulvovaginal Candidiasis
EMS
Large-scale testing (Phase 3)Looking for participantsNCT06835361
What this trial is testing

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

Who this might be right for
Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd. 264
Not applicableStudy completedNCT03900143
What this trial is testing

Safety, Efficacy and Usage Compliance of the Silk'n Tightra Device

Who this might be right for
Stress Urinary IncontinenceSexual DysfunctionVulvovaginal Atrophy
Home Skinovations Ltd. 28
Post-approval studies (Phase 4)Study completedNCT05562518
What this trial is testing

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Who this might be right for
Vulvovaginal AtrophyBreast Cancer
University Hospital, Ghent 31
Testing effectiveness (Phase 2)UnknownNCT06450990
What this trial is testing

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Who this might be right for
Bacterial VaginosisVulvovaginal Candidiasis
NEXBIOME THERAPEUTICS 165
Large-scale testing (Phase 3)Study completedNCT04232813
What this trial is testing

Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

Who this might be right for
Vulvovaginal Atrophy
Instituto Palacios 120
Testing effectiveness (Phase 2)UnknownNCT05059145
What this trial is testing

A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis

Who this might be right for
Candidiasis, Vulvovaginal
Karolinska Institutet 60
Not applicableStudy completedNCT02295579
What this trial is testing

Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida

Who this might be right for
Bacterial Vaginosis
Skaraborg Hospital 50
Not applicableStudy completedNCT03647189
What this trial is testing

Randomized, Controlled Trial With Hybrid Fractional Laser

Who this might be right for
Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
Sciton 25
Testing effectiveness (Phase 2)Study completedNCT01926028
What this trial is testing

Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis

Who this might be right for
Vulvovaginal Candidiasis
NovaDigm Therapeutics, Inc. 188
Post-approval studies (Phase 4)Study completedNCT02784613
What this trial is testing

Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

Who this might be right for
Vulvovaginal AtrophyDyspareunia
Sue Goldstein 10
Large-scale testing (Phase 3)Ended earlyNCT05243563
What this trial is testing

Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?

Who this might be right for
Vulvar Lichen Sclerosus
University of South Alabama 11
Not applicableStudy completedNCT01512498
What this trial is testing

Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche

Who this might be right for
Graft-vs-Host Disease
Hadassah Medical Organization 70
Not applicableStudy completedNCT07250490
What this trial is testing

Psychometric Validation of the Portuguese DIVAS-Q in Women With Vulvovaginal Atrophic Symptoms

Who this might be right for
Vulvovaginal AtrophyGenital DisorderPROMs
Instituto Politécnico de Leiria 300
Large-scale testing (Phase 3)Looking for participantsNCT05367089
What this trial is testing

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Who this might be right for
Candidiasis, VulvovaginalRecurrent Candidiasis of Vagina
Maastricht University Medical Center 252
Large-scale testing (Phase 3)Study completedNCT03734991
What this trial is testing

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

Who this might be right for
Candida Vulvovaginitis
Scynexis, Inc. 376
Next Page